Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Ainos Inc (AIMD)

Ainos Inc (AIMD)
0.5000 x 1 0.5200 x 2
Post-market by (Cboe BZX)
0.5211 +0.0411 (+8.56%) 03/14/25 [NASDAQ]
0.5000 x 1 0.5200 x 2
Post-market 0.4868 -0.0343 (-6.58%) 18:48 ET
Quote Overview for Fri, Mar 14th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.4680
Day High
0.5227
Open 0.4849
Previous Close 0.4800 0.4800
Volume 75,300 75,300
Avg Vol 241,210 241,210
Stochastic %K 29.26% 29.26%
Weighted Alpha -65.07 -65.07
5-Day Change +0.0321 (+6.56%) +0.0321 (+6.56%)
52-Week Range 0.4000 - 1.5000 0.4000 - 1.5000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,042
  • Shares Outstanding, K 15,433
  • Annual Sales, $ 20 K
  • Annual Income, $ -14,860 K
  • EBIT $ -9 M
  • EBITDA $ -8 M
  • 60-Month Beta 1.51
  • Price/Sales 352.75
  • Price/Cash Flow N/A
  • Price/Book 0.42
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.65
  • Most Recent Earnings $-0.26 on 03/07/25
  • Next Earnings Date 03/14/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4237 +22.99%
on 03/11/25
Period Open: 0.7390
0.7400 -29.58%
on 02/18/25
-0.2179 (-29.49%)
since 02/14/25
3-Month
0.4210 +23.78%
on 12/17/24
Period Open: 0.4400
1.0000 -47.89%
on 01/10/25
+0.0811 (+18.43%)
since 12/13/24
52-Week
0.4000 +30.27%
on 11/15/24
Period Open: 1.2900
1.5000 -65.26%
on 03/18/24
-0.7689 (-59.60%)
since 03/14/24

Most Recent Stories

More News
Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose’s Potential in Chip Manufacturing and More

Another key win in expanding AI Nose's industrial opportunities

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing

Harnessing AI-Powered Scent Digitization for Smarter, Safer, and More Sustainable Factories

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Ainos Reports Full Year 2024 Financial Results

Unveiled revolutionary AI Nose for robotics application, inviting global robotics companies to join Ainos Alliance in shaping the future of smell-enabled robots

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here

Practical partnership for AI Nose, multiple new opportunities

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Ainos and ugo to Develop the World's First Robot With a Sense of Smell

A Major Breakthrough in Ainos' Mission to Digitize Scent

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

Revolutionary Oral Interferon Technology Combines Unmatched Advantages and Global Potential in the $16 Billion Coronavirus Market

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025

Report highlights greater visibility in AI Nose developments, including robotics, smart manufacturing, elderly care monitoring, and women's health testing

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

SAN DIEGO, CA / ACCESS Newswire / January 17, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), today announced that it had received written notification (the "Written Notification")...

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots

Ainos invites robotics and humanoid companies to join Ainos Alliance and digitize smell

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

The following CORRECTS and REPLACES the release that was issued earlier today: Updated partner for VOC detection platform development

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

From giving AI the sense of smell and breakthrough in rare disease treatments, Ainos is shaping 2025 with bold technologies and strategic collaborations

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

SAN DIEGO, CA / ACCESSWIRE / December 13, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing...

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

SAN DIEGO, CA / ACCESSWIRE / December 4, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing...

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug

San Diego, California--(Newsfile Corp. - December 2, 2024) - Ainos, Inc. (NASDAQ: AIMD) (NASDAQ: AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care...

AIMD : 0.5211 (+8.56%)
Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

Prioritizing VELDONA®'s development for oral warts in HIV+ patients and Sjogren's syndrome

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug

The clinical study of new potential VELDONA-based animal drug is poised to expand VELDONA's market.

AIMD : 0.5211 (+8.56%)
Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan

First Batch of 300,000 Units to be Fully Delivered in October

AIMD : 0.5211 (+8.56%)
AIMDW : 0.2500 (+40.21%)
Ainos (NASDAQ: AIMD) Enters MoU with Merdury to Explore Phase 3 Study of VELDONA

Ainos, Inc. (NASDAQ: AIMD) is engaged as a diversified medical technology company, which is focused on developing innovative point-of-care testing

AIMD : 0.5211 (+8.56%)
Ainos Publishes Preclinical Data Demonstrating its VELDONA Formulation's Potential as Treatment Candidates for the Most Common Medical Conditions for Companion Animals

/PRNewswire/ -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care...

AIMD : 0.5211 (+8.56%)
Ainos Reports Unaudited Third Quarter 2022 Financial Results

/PRNewswire/ -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care...

AIMD : 0.5211 (+8.56%)

Business Summary

Ainos Inc. is a diversified healthcare company. It engaged in the discovery and development of pharmaceutical and biotech products. The company introduce novel products that actively stimulate and rejuvenate the human body to combat disease and enhance the ability to heal. Ainos Inc., formerly known...

See More

Key Turning Points

3rd Resistance Point 0.5946
2nd Resistance Point 0.5586
1st Resistance Point 0.5399
Last Price 0.5211
1st Support Level 0.4852
2nd Support Level 0.4492
3rd Support Level 0.4305

See More

52-Week High 1.5000
Fibonacci 61.8% 1.0798
Fibonacci 50% 0.9500
Fibonacci 38.2% 0.8202
Last Price 0.5211
52-Week Low 0.4000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.